ID
14928
Description
This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Check for Study Continuation
Keywords
Versions (1)
- 5/8/16 5/8/16 -
Uploaded on
May 8, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Check for Study Continuation Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396
Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
Description
Check for Study Continuation
Description
Yes, Please complete the next pages No, Please tick the ONE most appropriate reason and skip the following pages of this visit.
Data type
boolean
Alias
- UMLS CUI [1]
- C2827364
Description
If Serious adverse event - Please complete and submit SAE report - Please specify SAE No. If Non-Serious adverse event - Please complete Non-serious Adverse Event section - Please specify AE No. or solicited AE code If Other, please specify (e.g.: consent withdrawal, Protocol violation, ... )
Data type
text
Alias
- UMLS CUI [1,1]
- C0679823
- UMLS CUI [1,2]
- C0392360
Description
Code of SAE,AE,solicited AE or specification
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Who made the decision
Data type
text
Alias
- UMLS CUI [1]
- C1389424
Description
Laboratory Tests:Blood Sample
Similar models
Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
C0805701 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])